EUVIMEDEUVIMED entdecken
Crossref

An Ii-Key-containing HPV16/18 E7 epitope peptide vaccine promotes dendritic cell activation and T-cell immunity in a murine HPV16 tumor model, with greater tumor control upon PD-1 blockade

Zixuan Li, Liangliang Shen, Xiaoning Wang, Hu Ren, Chun Cui, Xiaoqian Tao, Xiaohui Yao, Xiaoyan Wang, Yuji Wang, Jin Qiu, Yu Lu, Shaobo Wang und 2 weitere

International Immunopharmacology · 2027-01 · 192 · 117694

DOI: 10.1016/j.intimp.2026.117694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2027-01. Verfasst von Zixuan Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmaceutical Sciences, Fudan University, Shanghai 201203, China. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Cervical cancerDendritic cell activationEarly-intervention TC-1 modelHPV16/18 E7Ii-Key strategyPD-1 blockadePeptide vaccine

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmaceutical Sciences, Fudan University, Shanghai 201203, China.
  • Beijing Youfeng Biological Technology Co., Ltd., Beijing 100176, China.
  • Beijing Youfeng Biological Technology Co., Ltd., Beijing 100176, China; Department of Medicinal Chemistry, College of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China.
  • Department of Medicinal Chemistry, College of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China; Beijing Key Laboratory of Intelligent Clinical Data and AI-Driven Innovative Drug Development, Be…
  • Department of Obstetrics and Gynecology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.
  • Beijing Youfeng Biological Technology Co., Ltd., Beijing 100176, China. Electronic address: wangshaobo@youfeng-bj.com.

Zitieren

APA

Li, Z., Shen, L., Wang, X., Ren, H., Cui, C., Tao, X., Yao, X., Wang, X., Wang, Y., Qiu, J., Lu, Y., Wang, S., Wang, F., & Zhang, X. (2027). An Ii-Key-containing HPV16/18 E7 epitope peptide vaccine promotes dendritic cell activation and T-cell immunity in a murine HPV16 tumor model, with greater tumor control upon PD-1 blockade. International Immunopharmacology, 192, 117694. https://doi.org/10.1016/j.intimp.2026.117694

Vancouver

Li Z, Shen L, Wang X, Ren H, Cui C, Tao X, et al. An Ii-Key-containing HPV16/18 E7 epitope peptide vaccine promotes dendritic cell activation and T-cell immunity in a murine HPV16 tumor model, with greater tumor control upon PD-1 blockade. International Immunopharmacology. 2027;192:117694. doi:10.1016/j.intimp.2026.117694

BibTeX
@article{Li2027,
  author = {Li, Zixuan and Shen, Liangliang and Wang, Xiaoning and Ren, Hu and Cui, Chun and Tao, Xiaoqian and Yao, Xiaohui and Wang, Xiaoyan and Wang, Yuji and Qiu, Jin and Lu, Yu and Wang, Shaobo and Wang, Feng and Zhang, Xuemei},
  title = {An Ii-Key-containing HPV16/18 E7 epitope peptide vaccine promotes dendritic cell activation and T-cell immunity in a murine HPV16 tumor model, with greater tumor control upon PD-1 blockade},
  journal = {International Immunopharmacology},
  year = {2027},
  volume = {192},
  pages = {117694},
  doi = {10.1016/j.intimp.2026.117694}
}
Kostenlos starten →